News

FDA approved caplacizumab for pediatric patients ≥12 years with acquired TTP, supported by retrospective data showing 80% remission.

A look back at the FDA submissions and regulatory decisions in the pediatric health care space from December 2025.

With the priority review, the Prescription Drug User Fee Act date is set for April 29, 2026, for potential approval in this younger indication.

Effective immediately, the updated US childhood vaccine schedule will reduce the number of recommended vaccines for all children to 11 diseases, down from 18.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

View our Q4 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.

Daniela Carvalho, MD, highlighted the role of pediatricians in guiding families through early hearing intervention and language development decisions.

The FDA approved narsoplimab-wuug as the first targeted treatment for transplant-associated thrombotic microangiopathy in adults and children.

Those with regular access to care who did not receive, or were late on 2- and 4-month recommended vaccines, were more likely to not have any MMR vaccine by 2 years of age.

Check the top pediatric conferences of 2025.

These were the most-viewed articles on the Contemporary Pediatrics website published in 2025.

Check out the top 5 nutrition articles of 2025.

As we continue our Countdown to 2026, take a look back at our top video interviews and packages of 2025.

Check out the top 5 nutrition articles of 2025.

In this recap article, take a look back at some of our top stories in the infectious diseases space in 2025.

Check out the top 5 nutrition articles of 2025.

Check out the top 5 pharmacology articles of 2025.

Join us for a recap of some of our top dermatology puzzler cases from 2025.

Can you guess what condition Tiny Tim had?

Prenatal exposure to hot, humid conditions was associated with significantly reduced child growth, with effects far greater than heat alone.

Mimi C. Lee, MD, PhD, outlines why genomic sequencing remains a powerful but carefully targeted tool in pediatric medicine today, as advancements continue.

National EHR data show vitamin K nonreceipt among newborns nearly doubled from 2017 to 2024, raising concern for preventable bleeding risk.

“We started out 2025 with an environment that was rife with myths and disinformation," said Robert H. Hopkins, Jr., MD, in this year-end recap of 2025 and the pediatric vaccine landscape.

Approval of the expanded indication fullfilled all post-marketing requirements outlined in the original approval letter.

Teen use of alcohol, cannabis, and nicotine remained stable in 2025, while daily energy drink use rose and heroin and cocaine use showed small increases.

Daniela Carvalho, MD, explained how the FDA-approved Nexa cochlear implant system may reduce interruptions in hearing for children while reinforcing the need for infection prevention.

Ferric maltol is now an FDA-approved oral iron therapy for both adults and adolescents with iron deficiency, aged 10 years and older.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.